Coartem
Active Ingredient(s): Artemether + LumefantrineFDA Approved: * April 7, 2009
Pharm Company: * NOVARTIS PHARMS
Category: Malaria
Artemether/lumefantrine, sold under the trade name Coartem among others, is a combination of the two medications artemether and lumefantrine.[1] It is used to treat malaria caused by Plasmodium falciparum that is not treatable with chloroquine.[1] It is not typically used to prevent malaria.[1] It is taken by mouth.[1] Common side effects include muscle and joint pains, fever, loss of appetite, and headache.[1] Se... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion
Dosage List
Coartem (Artemether 20 mg / Lumefantrine 120 mg) Oral Tablet
NDC: 0078-0568
Labeler:
Novartis Pharmaceuticals Corporation
